Login
$AGMB
$5.97 -$0.39 (6.13%) Live

Company Executives

Officer Age In this role Source
Tim Knotnerus Also a director
Chief Executive Officer and Executive Director
43 Since 2019
7 years
Pierre Thadee Victor Kemula
Chief Financial Officer
Title from the Form 4 dated Oct 6, 2026
Not stated Not stated
Philippe Wiesel
Chief Medical Officer
Not stated Since 2021
5 years
Andrea Sáez
Chief Development Officer
Not stated Since 2023
3 years
Paul van der Horst
Chief Business Officer
Not stated Since 2021
5 years
Ellen Lefever
General Counsel
Not stated Since 2021
5 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
6
serving now
Average tenure
3.7 years
from year joined
CEO also chairs the board
No
David Epstein
Director Age On board Committees Pay Source
David Epstein
64 2024
2 years
None stated Not stated
Tim Knotnerus
43 2021
5 years
None stated Paid as CEO
Angelika Jahreis
60 2023
3 years
Remuneration, nomination and corporate governance committee
Not stated
Colin Bond
66 2024
2 years
Audit committee · Chair Remuneration, nomination and corporate governance committee
Not stated
Felice Verduyn-van Weegen
39 2023
3 years
Audit committee Remuneration, nomination and corporate governance committee · Chair
Not stated
Ohad Hammer
45 2019
7 years
Audit committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. AgomAb Therapeutics NV has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support